Table 1.
Baseline characteristics of the iron-deficient CKD cohort and the hyperferritinemic hemodialysis cohort
| Cohort | CKD | HD |
|---|---|---|
| N | 25 | 15 |
| Age (years) | 65 ± 15 | 61 ± 12 |
| Gender (male/female) | 17/8 | 10/5 |
| Serum creatinine | 296 ± 130 | — |
| Hemoglobin (g/L) | 107 ± 8 | 116 ± 9 |
| Transferrin saturation (%) | 15 ± 6 | 31 ± 10 |
| Ferritin (mg/L) | 67 ± 56 | 782 ± 170 |
| CRP (mg/L) | 1.2 ± 2.6 | 4.9 ± 4.1 |
| Transfusions (N) | 0 | 3.8 ± 2.7 |
| Time on dialysis (days) | — | 899 ± 353 |
| Cumulative Fe dose (mg) | — | 6560 ± 3098 |
| Mean monthly Fe dose (mg) | — | 217 ± 87 |
| Weekly erythropoietin dose (U/wk) | — | 7870 ± 4360 |
| Liver Fe concentration (μmol/g) | 20.6 ± 7.9 | 81.2 ± 58.3 |